Navigation Links
Synutra International, Inc. Amends August 2005 Current Report on Form 8-K and Annual Report on Form 10-K for the Fiscal Year Ended March 31, 2007
Date:1/15/2008

QINGDAO, China and ROCKVILLE, Md., Jan. 15 /Xinhua-PRNewswire/ -- Synutra International, Inc. (Nasdaq: SYUT; ''Synutra''), one of China's leading manufacturers of dairy-based nutritional products for infants, children and adults, today filed amendments to its Current Report on Form 8-K filed on August 22, 2005 and its Annual Report on Form 10-K for the fiscal year ended March 31, 2007 with the U.S. Securities and Exchange Commission. As explained in the Forms 8-K and 10-K, the amendments are the result of certain deficiencies and errors in Synutra's financial statements identified during its ongoing assessment process to improve the effectiveness of its disclosure controls and procedures and internal control over financial reporting.

Synutra previously concluded that the audited consolidated Balance Sheets, Income Statements and Cash Flow Statements as of and for the calendar years ended December 31, 2003 and 2004 and unaudited consolidated Balance Sheets, Income Statements and Cash Flow Statements as of and for the three and six months ended June 30, 2004 and 2005 of its wholly owned subsidiary, Synutra Inc. (''Synutra Illinois''), should no longer be relied upon because of errors in such financial statements. The Current Report on Form 8-K filed today restates Synutra Illinois' financial statements to (i) reclassify certain other income as sales revenue and (ii) breakout certain cash and cash equivalents into cash and restricted cash line items.

Synutra also previously concluded that certain filings made subsequent to the Form 8-K filed on August 22, 2005, including Synutra's Annual Report on Form 10-K for the fiscal year ended March 31, 2007 and Amendment No. 1 to the Annual Report on Form 10-K for the fiscal year ended March 31, 2007, which presented audited financial statements covering the 12-month periods ended March 31, 2005, 2006, and 2007 (together, the ''Form 10-K"), should have presented, but did not present, audited financial statem
'/>"/>

SOURCE Synutra International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Nasdaq Informs Synutra that the Companys Filing Delinquency has been Cured
2. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
3. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
4. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
5. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
6. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
7. Chindex International, Inc. Announces Results for the Quarter and Six Months Ended September 30, 2007
8. DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results
9. Chindex International, Inc. Announces Transfer to NASDAQ Global Market
10. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
11. Z Trim Holdings Reports Restatement of Previously Issued Financial Statements; Amends Bylaws
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... paper recently published in the New England Journal ... at the University of Colorado School of Medicine finds ... can be used to identify individuals at risk for ... fairly common variant of the gene for mucin-5B, a ... by the bronchial tubes. While this variant of the ...
(Date:5/21/2013)... of Defense Serum Repository (DoDSR), University of Cincinnati (UC) ... bowel disease (IBD), which could help with earlier diagnosis ... symptoms. , This finding, the first of its kind ... presented via podium presentation by staff from Walter Reed ... being held May 18-21 in Orlando, Fla. , ...
(Date:5/21/2013)... New York (PRWEB) May 21, 2013 ... surgery robot lawsuit is nearing its conclusion in ... to Bloomberg.com, during closing statements yesterday, an attorney for ... alleging the company wanted to tie sales and services ... all the training to keep control of surgeons, to ...
(Date:5/21/2013)... May 21, 2013 Go Classy Tours, ... that they have redesigned their website featuring N ... pool, hot tubs, bars and dining. The website, which ... including sales and guest reviews, will now have a ... itself, including pages on culinary local recipes, flora and ...
(Date:5/21/2013)... While North Carolina is synonymous with golf, ... Brunswick Plantation & Golf Resort is synonymous with affordable ... 27 holes of "Top10" championship golf. , With ... the Top 10 from an industry expert ... task of selecting the course to play. Guests staying ...
Breaking Medicine News(10 mins):Health News:Researchers find genetic risk factor for pulmonary fibrosis 2Health News:Biomarkers discovered for inflammatory bowel disease 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4Health News:The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography 2Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2
... YORK, Oct. 6 In support of Breast Cancer Awareness ... ages with a collection of fashionable "pink" products. Touting ... of the American Cancer Society (ACS). , (Photo: ... Whether young or old, many of us have witnessed ...
... ... in the parts washing industry. Midbrook has extensive experience washing parts and equipment in a ... Washing facility to help a North American automotive parts supplier solve a de-rusting issue. ... (Vocus) October 6, 2009 -- ...
... ... factors when selecting a Medicare plan , ... Belleville, Ill. (Vocus) – People with disabilities have crucial healthcare ... a nationwide provider of Social Security disability representation and Medicare services. , , ...
... ... CSHL Fellow and Faculty Investigator, made major discoveries in telomere biochemistry and regulation ... Cold Spring Harbor, ... Carol Greider, Ph.D., has been named a Nobel Laureate, Cold Spring Harbor Laboratory President ...
... ... Australian Securities Exchange-listed oncology biotechnology company, announced today an AU$7,230,000 investment by SpringTree ... exclusive financial advisor to SpringTree,s general partner SpringTree Global Investors, LLC on the ... ...
... HEIGHTS, N.Y., Oct. 6 In an effort to build a ... are drilling nano-sized holes in computer-like chips and passing DNA strands ... genetic code. , View video: http://www.youtube.com/watch?v=pKi30ai35mU ... , For an ongoing conversation on this research ...
Cached Medicine News:Health News:This October Lady Foot Locker Is Fashioned for a Cause 2Health News:Midbrook Production Washing A Valuable Partner 2Health News:Midbrook Production Washing A Valuable Partner 3Health News:People with Disabilities Face Unique Healthcare Coverage Challenges, Allsup Says 2Health News:People with Disabilities Face Unique Healthcare Coverage Challenges, Allsup Says 3Health News:People with Disabilities Face Unique Healthcare Coverage Challenges, Allsup Says 4Health News:People with Disabilities Face Unique Healthcare Coverage Challenges, Allsup Says 5Health News:People with Disabilities Face Unique Healthcare Coverage Challenges, Allsup Says 6Health News:Cold Spring Harbor Laboratory's President Congratulates Alumna on Winning Nobel Prize 2Health News:KTA Capital Advises SpringTree Global Investors on an AU$7.2 Million Investment in HealthLinx Ltd 2Health News:IBM Research Aims to Build Nanoscale DNA Sequencer to Help Drive Down Cost of Personalized Genetic Analysis 2Health News:IBM Research Aims to Build Nanoscale DNA Sequencer to Help Drive Down Cost of Personalized Genetic Analysis 3Health News:IBM Research Aims to Build Nanoscale DNA Sequencer to Help Drive Down Cost of Personalized Genetic Analysis 4
(Date:5/21/2013)... Wash. , May 21, 2013  IsoRay, Inc. ... today that it has entered into an exclusive international ... IsoRay,s complete product line in Greece ... in seed brachytherapy and medical radioisotope applications for brain ... and gynecologic ("gyn") cancer. IASIS Medical ...
(Date:5/21/2013)... -- Vasomedical, Inc. (OTC BB: VASO) (the "Company"), a diversified medical ... medical devices and in the domestic sale of diagnostic imaging ... , President and CEO of Vasomedical, Inc. will present at ... 30, 2013 in New York City ... presentation is scheduled to begin at 9:30 a.m. EDT. ...
(Date:5/21/2013)... and TARRYTOWN, N.Y. , ... NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today ... published online the positive Phase 2a study results ...  Dupilumab is an investigational monoclonal antibody targeting the alpha ... modulates signaling of both IL-4 and IL-13, drivers of ...
Breaking Medicine Technology:IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7
... Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ) ... results after the market closes on Wednesday, May 4, 2011. ... on Wednesday, May 4, 2011 at 5:00 p.m. Eastern Time ... call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for ...
... 21, 2011 Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ... and live webcast on Tuesday, May 3, 2011 at 4:30 ... management will provide a business and financial update and review ... and press release may be accessed from the Investors section ...
Cached Medicine Technology:
... Precision Hand Instruments were developed in surgeon's ... while still having an instrument with the ... the fear of the bending or breaking. ... manufactured to conform to the surgeon's hand. ...
This optimal design addresses low-cost, simple, non-invasive ankle distraction....
... Clinical Lab Accuracy The Q.E.D.® ... an accurate screen in place ... In clinical trials, saliva alcohol ... demonstrated high correlation to blood ...
ThyroTest by ThyroTec, Inc. is a rapid immunoassay, similar to a rapid pregnancy test. By using 2 drops of blood from a finger stick and 5 drops of diluent, a qualitative TSH level is inicated in min...
Medicine Products: